The Latest Cardiac and Vascular News
IRVINE, Calif., March 18, 2021 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of differentiated pericardial transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, announces the appointment of Jane Metcalf to Vice President, Regulatory Affairs and Quality, effective immediately. Ms. Metcalf comes to JenaValve […]
Topline data from Phase 2b clinical trial evaluating rNAPc2 as a potential treatment for COVID-19 anticipated in the third quarter of 2021 New patent issued by USPTO for use of Gencaro in treating atrial fibrillation in heart failure patients with ejection fractions greater than 40% WESTMINSTER, Colo., March 18, 2021 […]
New Board Appointment Brings Demonstrated Leadership in the Medical Device Industry CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Acutus Medical (Nasdaq: AFIB) today announced the appointment of John Sheridan to the Company’s Board of Directors effective March 17, 2021. Since March 2019, Mr. Sheridan has been the President and […]
CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourth quarter and full year ended December 31, 2020. Recent Highlights: Reported revenue of $2.6 million […]
MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced the pricing of an underwritten public offering of 16,000,000 shares of its common stock at a public offering price of $3.50 per […]
POSEIDON – positive interim results in Q4 2020; additional interim results expected in Q2 2021 and primary endpoint in Q2 2022 RED DESERT – positive interim results in Q4 2020; top-line data expected in Q2 2021 Successful equity placements extend cash runway into Q2 2022 Conference call with live webcast today at […]
March 8, 2021, filing to raise up to $75 million. Maximum of 1,500,000 shares of Series B preferred stock offered at price of $50 per share. Healthtech Solutions, Inc. is organized to pursue innovation in the field of medical technology. NEW YORK, March 17, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Healthtech […]
Menlo Ventures, UCHealth invest to bring comprehensive hypertension measurement and management to the phone PALO ALTO, Calif.–(BUSINESS WIRE)–Riva Health, a new mobile cardiology app, today announced $15.5M in funding led by Menlo Ventures. UCHealth and University of Colorado Innovation Fund also participated in the round, as well as leading Chicago healthcare […]
LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: 2020 highlights and results Global strategic partnership with Nestlé Health Science for the development and marketing of TOTUM-63, a plant-based active substance with clinically proven metabolic health benefits in prediabetic subjects. Launch of REVERSE-IT, a global pivotal Phase II/III clinical trial of TOTUM-63 for reducing […]
–Galaxy’s proprietary CENTAURI™ system on track for EU registration and US pivotal trial start later this year; shows best-in-class potential SAN CARLOS, Calif., March 16, 2021 /PRNewswire/ — ATP, a leader in life science venture capital, announced today $18M in Series A financing for its portfolio company Galaxy Medical, Inc. The funds are being […]
